Literature DB >> 8482487

Subtype of muscarinic receptors mediating relaxation and contraction in the rat iris dilator smooth muscle.

K Shiraishi1, I Takayanagi.   

Abstract

1. Carbachol produced a relaxation of dilator muscle at a concentration lower than 1 microM and a contraction at a concentration higher than 1 microM. 2. We studied the effects of the M1-selective antagonist, pirenzepine, the M2-selective antagonist, himbacine, the M3-selective antagonist, 4-diphenyl-acetoxy-N-methylpiperidine methiodide (4-DAMP) and the non-selective antagonist, atropine, on carbachol-induced relaxation and contraction of the rat iris dilator smooth muscle. All the antagonists competitively inhibited both the responses to carbachol. 3. In relaxation and contraction, the low affinity of pirenzepine and himbacine suggest that the rat iris dilator smooth muscle receptors are not of the M1 and M2 subtypes. In contrast, 4-DAMP potently inhibited the carbachol-induced relaxation and contraction with affinities similar to those reported for the M3 subtype. 4. Carbachol-induced relaxation and contraction of the rat iris dilator appears to be mediated through a homogeneous population of M3 subtype.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8482487     DOI: 10.1016/0306-3623(93)90024-r

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  3 in total

1.  A comparison of scopolamine and biperiden as a rodent model for cholinergic cognitive impairment.

Authors:  Inge Klinkenberg; Arjan Blokland
Journal:  Psychopharmacology (Berl)       Date:  2011-02-19       Impact factor: 4.530

2.  Efficacy assessment of a combined anticholinergic and oxime treatment against topical sarin-induced miosis and visual impairment in rats.

Authors:  A Gore; E Bloch-Shilderman; I Egoz; J Turetz; R Brandeis
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

3.  Blockade of muscarinic receptors impairs the retrieval of well-trained memory.

Authors:  Shogo Soma; Naofumi Suematsu; Satoshi Shimegi
Journal:  Front Aging Neurosci       Date:  2014-04-08       Impact factor: 5.750

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.